Peptides from soybeans may influence the immune system and hormones linked to emotion, and ultimately boost brain function, according to a new Sino-Japanese study.
Growing numbers of part-time vegetarians, or ‘flexitarians’, are feeding demand for soy products, says the chief of the biggest soy supplier in the world, who refutes suggestions the soy market is flattening out in some regions.
Israeli soy player Solbar was acquired by the US farmers co-op, CHS last month, an acquisition the company welcomes for more than just financial reasons after some difficult years.
The United States’ biggest farmer-owned cooperative CHS Inc. has signed an agreement to acquire soy protein company Solbar for $133m, sending share prices in the Israeli company soaring.
Food, drink and supplement makers across the European Union’s 27-member states are free to make cholesterol-lowering health claims after an oat beta-glucan health claim passed into EU law books yesterday.
Soy protein, but not milk protein or carbohydrate, supplementation may improve the lipid profile among healthy individuals by increasing levels of ‘good’ cholesterol, suggests a new study.
Supplementation with a synthetic version of the soy isoflavone genistein could reduce tissue biomarkers of prostate cancer after just a few weeks, according to new research.
A Brussels-based pan-European trade group says it is encouraged by interactions with MEPs who are set to play an active role in scrutinising and potentially modifying controversial European Union health claim rejections.
European health claim experts say the devil may be in the detail of two positive European Food Safety Authority (EFSA) health claim opinions for red yeast rice and creatine that featured in the final batch of article 13, general function claims issued...
The European Food Safety Authority has completed the gargantuan task of assessing thousands of general function, article 13 health claims with a controversial soy isoflavone rejection featuring in its last mini-batch of five opinions.
Just days after its soy protein-cholesterol reduction health claim was writ into the European Union register of rejected claims, the soy industry has re-entered the game with a fresh submission it says has learnt hard lessons from last year’s EFSA rebuttal.
The birthplace of functional foods, Japan, continues to be the world’s most robust with 38.4% of a global functional food market of $24.22bn (€16.75bn), according to a Leatherhead report utilising tight functional food definitions.
Alpro, the leading European soy player its chief says has “sustainability in its DNA”, has become the first European food company to sign up to the World Wildlife Fund’s Climate Savers programme.
Eight of the top 12 soy drink consuming countries are Asian with Hong Kong residents consuming the most at 17 litres per year each, according to TetraPak data.
Business best practice thinktank Ethisphere has named DuPont-Bunge soy joint venture, Solae, among its most ethical companies in 2011 for the second year running.
In part four of this NutraIngredients heart health special we look at how regulators view those foods, drinks and supplements making cardiovascular claims
Lallemand Bio-Ingredients is promoting a new vegetarian form of vitamin D it says can make a considerable dent in global deficiencies in the ‘sun vitamin’ due its functional food flexibility.
Aging populations are driving growth in the global market for soy foods, as more people turn to soy for its health benefits, according to a new report from Global Industry Analysts, Inc. (GIA).
DuPont expects to become a ‘premier specialty food ingredients provider’ as a result of acquiring Danisco, and expects it to be particularly complementary to its Solae soy protein business.
Isoflavones in the aglycone form – as found naturally in fermented soy foods – are more bioavailable than the glucoside-form from non-fermented soy, says a new study from Japan.
2010 has been another tough year for the European functional food and supplements industries as health claim rejections have continued to flood in, leaving some in a state of high anxiety, fear and dread. Others are just mildly annoyed at a situation...
The European Food Safety Authority health claims panel has defended its controversial rejection of a soy protein-cholesterol lowering submission in July this year by highlighting the fact the industry agreed to its tight definition of soy protein.
New research from Solae backs up the claims for soy protein’s cholesterol lowering effect, but says the mechanism behind benefits is ‘yet to be determined’.
The rejection of so many health claim submissions by the European Food Safety Authority is creating a major headache for the EU functional foods and food supplements industries, with many looking at resubmissions under article 13.5 of the regulation.
Soy industry groups say they are actively lobbying the European Commission for dialogue after the European Food Safety Authority (EFSA) last week rejected a raft of soy-related health claims.
Solae Europe has debuted an insoluble fibre, soluble fibre and soy protein blend it says can support, “digestive health, heart health, and a lower glycaemic index for foods.”
The three groups behind the soy protein-cholesterol lowering health claim rejected by the European Food Safety Authority in late July, say EFSA’s tight definition of soy protein denies real world use of the nutrient.
Solbar has unveiled a new corporate branding image as it is engaged in a strategic shift towards innovation, especially in isolates soy protein and extruded products and supporting customers with technical knowhow.
Supplementation with soy isoflavones could improve blood vessel endothelial cell function and reduce cardiovascular disease risk factors, according a new meta-analysis study.
Protein from soy or casein both benefit the synthesis of muscle protein at the same rate, suggests a new study that supports both sources for muscle health.
Leading soy supplier Solae has criticised the European Food Safety Authority (EFSA) for a selective approach that saw the agency’s health claims panel dismiss upward of 30 human intervention studies contained in an article 14, soy protein, cholesterol-lowering...
Solae expects its new steariodonic acid omega-3 from genetically modified soybeans to be ready for market launch in 2012, and is now sending out samples so food manufacturers can test it in applications.
Solae is introducing new soy protein concentrates made using a patented membrane technology, which can replace or complement dairy proteins and are said to deliver good taste, functionality and nutritional value.
In the third part of our special series on sports nutrition, NutraIngredients looks at the reigning champions in sports ingredients and takes a look at the science behind new contenders to the crown.
A new study exposing oral nutrition supplements (ONS) to a ‘boredom test’ has found that unpleasant taste and mouthfeel effects build up with repeat consumption, potentially increasing risk of poor compliance with high-volume prescriptions.
Combining prebiotics and soy protein may lower cholesterol levels and boost heart health, effects not seen when prebiotic or soy were taken separately, says new research from Canada.
A new soy protein isolate with a bland flavour profile, which has low viscosity when subjected to the heat and shear of extrusion, was developed to meet the demands of the soy crisps, extruded snacks and cereals market, said Israeli firm Solbar Industries.
Increased intakes of soy and soy products may reduce the risk of death and breast cancer recurrence, says a new study in the Journal of the American Medical Association.
A compound often discarded as waste in soy-processing plants may stop inflammation, and protect against chronic diseases like diabetes and heart disease, says new research.
Treatment based on resveratrol could be a safer alternative to hormone replacement therapy (HRT) in postmenopausal women and could help prevent breast cancer, according to a new study.
Supplementation with soy-germ derived isoflavones may reduce the loss of bone in postmenopausal women, according to results of a new study from the US.
Phytoestrogens like soy and red clover isoflavones pose no safety issues with regards to heart health and breast cancer risk, according to a new meta-analysis from Austria.
